Research Study of How Well Semaglutide Works in People Living With Overweight or Obesity.

NCT04251156 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

375

Enrollment

INDUSTRY

Sponsor class

Conditions

Overweight
Obesity
Diabetes Mellitus, Type 2

Interventions

DRUG: Semaglutide
DRUG: Placebo (semaglutide)

Sponsor

Novo Nordisk A/S